Notice of Change to Key Dates in PAR-16-441 "Selected Topics in Transfusion Medicine (R21)"

Notice Number: NOT-HL-16-457

Key Dates
Release Date: September 30, 2016

Related Announcements
PAR-16-441

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

This Notice amends the Key Dates for applications submitted in Response to PAR-16-441 "Selected Topics in Transfusion Medicine (R21)".

Part 1. Key Dates

 

Current Key Dates:

Posted Date

September  22, 2016

Open Date (Earliest Submission Date)

January 16, 2017

Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Date(s)

February 16, 2017; October 16, 2017; February 16, 2018; October 16, 2018; February 16, 2019; October 16, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

May 7, 2017; January 7, 2018; May 7, 2018; January 7, 2019; May 7, 2019; January 7, 2020, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Scientific Merit Review

July 2017; March 2018; July 2018; March 2019; July 2019; March 2020

Advisory Council Review

August 2017; May 2018; August 2018; May 2019; August 2019; May 2020

Earliest Start Date

September 2017; July 2017; September 2018; July 2018; September 2019; July 2019

Expiration Date

January 8, 2020

Due Dates for E.O. 12372

Not Applicable

Updated Key Dates:   

Posted Date

September  22, 2016

Open Date (Earliest Submission Date)

October 21, 2016

Application Due Date(s)

November 21, 2016; February 16, 2017; October 16, 2017; February 16, 2018; October 16, 2018; February 16, 2019; October 16, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

January 7, 2017; May 7, 2017; January 7, 2018; May 7, 2018; January 7, 2019; May 7, 2019; January 7, 2020, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Scientific Merit Review

February 2017; July 2017; March 2018; July 2018; March 2019; July 2019; March 2020

Advisory Council Review

May 2017; October 2017; May 2018; October 2018; May 2019; October 2019; May 2020

Earliest Start Date

July 2017; November 2017; July 2017; November 2018; July 2018; November 2019; July 2020

Expiration Date

January 8, 2020

Due Dates for E.O. 12372

Not Applicable

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Shimian Zou, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: zousn@nhlbi.nih.gov